| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.00032 | 1 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.00033 | 1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |